Bridging Therapy's effects on clinical outcomes after commercial BCMA CAR T-cell therapy used in the standard of care treatment of relapsed and refractory multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Kimberly Burcher, Amber Feng, Terrell Coring, Taylor Addis, Emily Sellars, Melissa Martin, Tanya Bellavia, Lauren Jones, Daniel Schrum, Erin Eberwein, Erin Kennedy, Cristina Gasparetto, Cristiana Costa Chase, Taewoong Choi, Sendhilnathan Ramalingam, Gwynn Long, Suzanne Kirby, Chenyu Lin, Yubin Kang
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417013931
Cites:
Cited by:
Related to: